EYPT peer analysis
EyePoint (EYPT) against its competitors: price, today's move, 1-year return and market value side by side.
- EYPT's peers: BCAX (Bicara Therapeutics), KOD (Kodiak Sciences), KURA (Kura Oncology), NRIX (Nurix Therapeutics), PRME (Prime Medicine), PROK (ProKidney), RZLT (Rezolute), SEPN (Septerna).
EYPT and its peers
| Company | Price | Today | 1-year return | Market cap |
|---|---|---|---|---|
| BCAX Bicara Therapeutics | $8.44 | -7.46% | -44.40% | $560.31M |
| KOD Kodiak Sciences | $97.26 | -0.65% | 398.00% | $6.36B |
| KURA Kura Oncology | $6.94 | -5.58% | -38.69% | $637.64M |
| NRIX Nurix Therapeutics | $12.85 | -5.51% | -10.33% | $1.40B |
| PRME Prime Medicine | $3.56 | -7.29% | -4.30% | $647.64M |
| PROK ProKidney | $1.03 | -2.81% | -55.59% | $311.51M |
| RZLT Rezolute | $3.95 | -5.95% | -61.12% | $382.08M |
| SEPN Septerna | $38.61 | -1.51% | 67.14% | $1.84B |
| SVRA Savara | $4.30 | -17.47% | -6.52% | $948.68M |
| TNGX Tango Therapeutics | $22.00 | -3.13% | 165.54% | $3.73B |
| EYPT EyePoint | $0.24 | -9.71% | -98.33% | $27.14M |